New Impact of Hyperuricemia and Chronic Kidney Disease for the Patients with Carotid Endarterectomy

被引：0
|
作者：
Sayama, T. [1 ]
Shimogaw, T. [1 ]
Hamamura, T. [1 ]
Morioka, T. [1 ]
机构：
[1] Kyushu Rosai Hosp, Kitakyushu, Fukuoka, Japan
来源：
CEREBROVASCULAR DISEASES | 2013年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：70 / 71
页数：2
相关论文
共 50 条
  • [21] Hyperuricemia and the problem of chronic kidney disease
    Shcherbak, A. V.
    Kozlovskaya, L. V.
    Bobkova, I. N.
    Balkarov, I. M.
    Lebedeva, M. V.
    Stakhova, T. Yu.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (06) : 100 - 104
  • [22] Impact of chronic kidney disease on carotid plaque vulnerability
    Pelisek, Jaroslav
    Hahntow, Ines N.
    Eckstein, Hans-Henning
    Ockert, Stefan
    Reeps, Christian
    Heider, Peter
    Luppa, Peter B.
    Frank, Helga
    JOURNAL OF VASCULAR SURGERY, 2011, 54 (06) : 1643 - 1649
  • [23] Carotid endarterectomy and transcarotid artery revascularization can be performed with acceptable morbidity and mortality in patients with chronic kidney disease
    Elizaga, Norma
    Ghosh, Rahul
    Saldana-Ruiz, Nallely
    Schermerhorn, Marc
    Soden, Peter
    Dansey, Kirsten
    Zettervall, Sara L.
    JOURNAL OF VASCULAR SURGERY, 2024, 80 (02) : 431 - 440
  • [24] Carotid Endarterectomy Should Not Be Recommended to End-Stage Kidney Disease Patients with Asymptomatic Carotid Artery Disease
    Hafeez, Muhammad Saad
    Abdul-Malak, Othman M.
    Eslami, Mohammad H.
    Chaer, Rabih A.
    Yuo, Theodore H.
    ANNALS OF VASCULAR SURGERY, 2024, 101 : 53 - 61
  • [25] Impact of hyperuricemia and chronic kidney disease on the prevalence and mortality of cardiovascular disease in cancer survivors
    Chen, Yanlin
    Chen, Yuhan
    Lin, Weidong
    Fu, Lu
    Liu, Huiyi
    Pu, Sijia
    Chen, Haowei
    Yi, Hong
    Xue, Yumei
    CANCER MEDICINE, 2024, 13 (09):
  • [26] Efficacy of xanthine oxidase inhibitor for chronic kidney disease patients with hyperuricemia
    Matsuo, Hiroshi
    Ishikawa, Eiji
    Machida, Hirofumi
    Mizutani, Yasuhide
    Tanoue, Akiko
    Ohnishi, Takahiro
    Murata, Tomohiro
    Okamoto, Shinya
    Ogura, Toru
    Nishimura, Yuki
    Ito, Hiroo
    Yasutomi, Masashi
    Katayama, Kan
    Nomura, Shinsuke
    Ito, Masaaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2020, 24 (04) : 307 - 313
  • [27] Efficacy of xanthine oxidase inhibitor for chronic kidney disease patients with hyperuricemia
    Hiroshi Matsuo
    Eiji Ishikawa
    Hirofumi Machida
    Yasuhide Mizutani
    Akiko Tanoue
    Takahiro Ohnishi
    Tomohiro Murata
    Shinya Okamoto
    Toru Ogura
    Yuki Nishimura
    Hiroo Ito
    Masashi Yasutomi
    Kan Katayama
    Shinsuke Nomura
    Masaaki Ito
    Clinical and Experimental Nephrology, 2020, 24 : 307 - 313
  • [28] The Effectiveness and Safety of Febuxostat for Chronic Kidney Disease Patients with Gout and Hyperuricemia
    Huang, Chien-Huei
    Wang, Ming-Cheng
    Yen, Chi-Tai
    Cheng, Ching-Lan
    Liu, Pheng-Ying Yeh
    Chang, Hui-Jen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 435 - 436
  • [29] Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection
    Jan T. Kielstein
    Roberto Pontremoli
    Michel Burnier
    Current Hypertension Reports, 2020, 22
  • [30] Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection
    Kielstein, Jan T.
    Pontremoli, Roberto
    Burnier, Michel
    CURRENT HYPERTENSION REPORTS, 2020, 22 (12)
12345